Blade and others, it seems unlikely Dr. Teferri will face that elite of his subspecialty and have to backtrack his presentation. I think the message is evidence for disease modification not prev described with any other drug. bp
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.